← Back to all earnings calls

Serina Therapeutics, Inc. Q3 FY2023 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2023 Q3 Call date: 2023-11-14 NoCallHeld

Share

Quarter scorecard

Revenue

$29,000

+222.2% YoY

Diluted EPS

$0.23

Gross margin

117.2%

+72.8 pp YoY

Net income

$1.75M

Documents & deck